⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL533329 | 0.82 | — | — | |
| SCHEMBL7367240 | 0.77 | ALDH1A1 (0.35) | — | |
| SCHEMBL534479 | 0.77 | L3MBTL1 (0.50) | — | |
| SCHEMBL7366986 | 0.77 | HRH3 (0.45) | — | |
| SCHEMBL209787 | 0.76 | CHRNB2 (0.47) | — | |
| SCHEMBL4930125 | 0.76 | — | — | |
| SCHEMBL533685 | 0.76 | TDP1 (0.49) | — | |
| SCHEMBL1335859 | 0.76 | TDP1 (0.49) | — | |
| SCHEMBL11552400 | 0.73 | — | — | |
| SCHEMBL4414485 | 0.73 | NOS2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 353 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114213353-A | Aryl-oxazole-oxazoline compound and preparation method and application thereof | 贵州大学 | 2022-03-22 | — | — | CN | claimed |
| CN-107646034-B | 3- (6-chloro-3-oxo-3, 4-dihydro- (2H) -1, 4-benzoxazin-4-yl) propionic acid derivatives or their use as KMO inhibitors | 爱丁堡大学理事会 | 2021-06-15 | — | — | CN | claimed |
| CN-106414429-B | Pyrazole compounds and their use as T-type calcium channel blockers | 爱杜西亚药品有限公司 | 2020-01-03 | — | — | CN | claimed |
| US-10065929-B2 | Pyrazole compounds and their use as T-type calcium channel blockers | IDORSIA PHARMACEUTICALS LTD (CH) | 2018-09-04 | — | — | US | claimed |
| EP-3363788-A1 | CANNABINOID RECEPTOR MODULATORS | Arena Pharmaceuticals, Inc. (US) | 2018-08-22 | — | — | EP | claimed |
| US-20180105496-A1 | PYRAZOLE COMPOUNDS AND THEIR USE AS T-TYPE CALCIUM CHANNEL BLOCKERS | IDORSIA PHARMACEUTICALS LTD (CH) | 2018-04-19 | — | — | US | claimed |
| US-9932314-B2 | Pyrazole compounds and their use as T-type calcium channel blockers | IDORSIA PHARMACEUTICALS LTD (CH) | 2018-04-03 | — | — | US | claimed |
| US-20170096399-A1 | PYRAZOLE COMPOUNDS AND THEIR USE AS T-TYPE CALCIUM CHANNEL BLOCKERS | IDORSIA PHARMACEUTICALS LTD (CH) | 2017-04-06 | — | — | US | claimed |
| EP-2415763-B1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING GLAUCOMA | UBE INDUSTRIES (JP) | 2016-01-27 | — | — | EP | claimed |
| US-20140113907-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2014-04-24 | — | — | US | claimed |
| JP-H09502702-A | — | — | 1997-03-18 | — | — | JP | claimed |
| US-5554758-A | Method for producing ethers | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-09-10 | — | — | US | claimed |
| EP-0706514-A1 | COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES | MEDIVIR AB (SE) | 1996-04-17 | — | — | EP | claimed |
| WO-1995006034-A1 | COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES | MEDIVIR AB (SE) | 1995-03-02 | — | — | WO | claimed |
| EP-0612314-A1 | 2-HETEROCYCLICETHYLAMINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | Astra Aktiebolag (SE) | 1994-08-31 | — | — | EP | claimed |
| EP-0359377-B1 | 1,4-DIHYDROPYRIDINE DERIVATIVE | NIKKEN CHEMICALS CO., LTD. (JP) | 1993-10-13 | — | — | EP | claimed |
| WO-1993009095-A1 | 2-HETEROCYCLICETHYLAMINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | FISONS CORPORATION (US) | 1993-05-13 | — | — | WO | claimed |
| EP-0540318-A1 | 2-Heterocyclicethylamine derivatives and their use as pharmaceuticals | FISONS CORPORATION (US) | 1993-05-05 | — | — | EP | claimed |
| US-4985558-A | ANTITUMOR AGENTS | NIKKEN CHEMICALS CO., LTD. (JP) | 1991-01-15 | — | — | US | claimed |
| EP-0359377-A1 | 1,4-dihydropyridine derivative | NIKKEN CHEMICALS CO., LTD. (JP) | 1990-03-21 | — | — | EP | claimed |